Xueba’s medical black technology system

Chapter 64 Entering the third clinical phase

After Zhu Yeping finished breakfast, he hurried towards the hospital.

He is a doctor in the Department of Endocrinology. He is very busy during this period because he needs to take students for internship.

After picking up the hospital's sterilized white coat, Zhu Yeping walked towards the consulting room.

When he came to the corridor of the outpatient area, Zhu Yeping saw from a distance that the intern students he had brought were waiting at the door of the clinic.

At this moment, these intern students seemed to be discussing excitedly and did not notice that he had arrived.

Zhu Yeping didn't pay attention. He walked over and said hello: "You all came on time."

These intern students also noticed Zhu Yeping coming over at this time. They quickly stopped their discussion and greeted Zhu Yeping: "Hello, Teacher Zhu."

Zhu Yeping nodded, and then asked casually: "What were you discussing just now?"

Taking advantage of the gap before the patient came, Zhu Yeping planned to find some topic to chat with these students.

As Zhu Yeping spoke, the faces of the intern students showed impatient looks, and one of them said, "Teacher Zhu, have you heard about the drug for treating type 2 diabetes?"

Type 2 diabetes medication?

Zhu Yeping thought that the intern students were chatting about trivial matters in life, but unexpectedly they were discussing drug-related issues.

However, this student's question made Zhu Yeping feel a little puzzled: "What kind of medicine? Isn't there always only one kind of medicine for the treatment of type 2 diabetes?"

The student was a little surprised: "Teacher Zhu, don't you know? There are discussions on the Internet now about the new drug to treat type 2 diabetes."

Zhu Yeping smiled and shook his head: "I really don't know. After all, I am very busy during this period and rarely have time to pay attention to things on the Internet."

The students nodded suddenly. As a medical professor, Zhu Yeping, in addition to treating patients, also had to shoulder some scientific research work.

Basically, as soon as I get busy, I am so busy that I don’t have time to pay attention to things online.

However, after listening to the student's words, Zhu Yeping became curious.

He was primarily interested in the drug the student mentioned for treating type 2 diabetes.

He has been working in the Department of Endocrinology for so many years and has come into contact with countless patients with type 2 diabetes. However, for so many years, he has only been able to prescribe one drug to patients with type 2 diabetes, which is liraglutide. Some dietary advice.

Now that he suddenly heard about new treatment drugs, how could Zhu Yeping not be curious.

Zhu Yeping asked: "What is the new drug for treating type 2 diabetes that you are talking about? Has it passed the third phase of clinical trials? I haven't heard any new research progress on type 2 diabetes recently?"

Zhu Yeping asked several questions in one breath.

This made things difficult for the intern students. One of the intern students said with a queasy look on his face: "Teacher Zhu, we don't know much about this. Otherwise, teacher, you'd better see for yourself."

With that said, the student took out his mobile phone and opened Zhou Jun's video, and handed it to Zhu Yeping: "Teacher, you will know after you look at it."

After Zhu Yeping took the phone from the student, he put on his glasses and began to browse Zhou Jun's video carefully.

The video is not long overall, it only takes a few minutes, and Zhu Yeping finished it quickly.

After Zhu Yeping watched the video, one of the students asked curiously: "I see that many people are questioning it, and I don't know if it is true or not. Teacher, what do you think?"

After putting down his cell phone, Zhu Yeping said: "Indeed, if this drug called 'metformin' can be developed, it will definitely be good news for patients with type 2 diabetes."

"But for now, those who questioned are right. In one year, it is basically impossible." After listening to Zhu Yeping's words, several students suddenly showed a look of disappointment on their faces.

It seems that even Zhu Yeping, an old professor who has been practicing medicine for more than ten years, believes that it is impossible to launch a drug within one year.

Then, a student seemed to remember something, and he continued to ask: "Teacher, how soon do you think this 'Metformin' will be available?"

Zhu Yeping thought for a moment, then stretched out five fingers: "Judging from the current situation, the fastest and fastest, it will take at least five or six years."

This was after Zhu Yeping considered that Lu Liang had developed a drug to treat chronic myelogenous leukemia.

If it weren't for Lu Liang's successful experience, the time given by Zhu Yeping might have been longer.

Seeing the disappointed look of the intern student, Zhu Yeping smiled and comforted him: "It's okay. This is at least a big progress. There is still hope that we can see this kind of drug in the future."

At this moment, a shout sounded from behind Zhu Yeping: "Doctor Zhu."

Zhu Yeping looked back and found that the director of the Department of Endocrinology was calling him.

After Zhu Yeping put on his glasses, he looked at the director and asked, "Director, what's the matter?"

The director said: "That's it, Dr. Zhu, the hospital has recently launched a batch of clinical trials of drugs for type 2 diabetes."

"The dean attaches great importance to this clinical trial, and Dr. Zhu, you are familiar with type 2 diabetes, so the dean hopes that you will be in charge of these clinical trials."

Zhu Yeping looked a little surprised. He smiled and said, "What a coincidence. I was just discussing drugs to treat type 2 diabetes with students, and now there are new drugs entering clinical trials."

Several intern students also came up curiously to listen.

Later, Zhu Yeping asked: "Director, which phase of clinical trials have this batch of drugs reached?"

The director replied: "We are currently in the last phase, which is the third phase of clinical trials."

Zhu Yeping was a little surprised: "Then there is not much hope that this drug can pass clinical trials?"

The director also nodded: "So, the director does not hope that there will be any accidents in this clinical trial. After all, this is a domestically produced drug and needs our strong support."

"It's still a domestically produced drug." Zhu Yeping was even more surprised.

How long has it been since there was no breakthrough research progress and new drugs developed for type 2 diabetes?
Unexpectedly, this time the Chinese could lead foreign countries and take the lead in developing new drugs.

The director also expressed emotion: "Therefore, the director also attaches great importance to this clinical trial."

Zhu Yeping seemed to realize the heavy burden on his shoulders, and he quickly said: "I understand, director."

"Then it's all thanks to you, Dr. Zhu." The director also nodded.

Just as the director was about to leave after handing over his work, Zhu Yeping seemed to remember something. He asked curiously: "By the way, director, what is the name of this new drug?"

The director paused and thought for a while: "I remember the new drug is called metformin."

"Um?!"

Zhu Yeping's eyes suddenly widened, with an expression on his face that he had seen a ghost.

(End of this chapter)